BR9911917A - Composições compreendendo análogos de gaba e cafeìna - Google Patents
Composições compreendendo análogos de gaba e cafeìnaInfo
- Publication number
- BR9911917A BR9911917A BR9911917-0A BR9911917A BR9911917A BR 9911917 A BR9911917 A BR 9911917A BR 9911917 A BR9911917 A BR 9911917A BR 9911917 A BR9911917 A BR 9911917A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- gaba
- caffeine
- analogs
- caffeine analogs
- Prior art date
Links
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical class CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 abstract 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Chemical class CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Chemical class CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 2
- 229960001948 caffeine Drugs 0.000 abstract 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical class NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 229960002870 gabapentin Drugs 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9213198P | 1998-07-09 | 1998-07-09 | |
| PCT/US1999/013670 WO2000002562A1 (en) | 1998-07-09 | 1999-06-18 | Compositions comprising gaba analogs and caffeine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9911917A true BR9911917A (pt) | 2001-03-27 |
Family
ID=22231777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9911917-0A BR9911917A (pt) | 1998-07-09 | 1999-06-18 | Composições compreendendo análogos de gaba e cafeìna |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6326374B1 (enExample) |
| EP (1) | EP1094817A1 (enExample) |
| JP (1) | JP2002520286A (enExample) |
| KR (1) | KR20010071777A (enExample) |
| AU (1) | AU772156B2 (enExample) |
| BR (1) | BR9911917A (enExample) |
| CA (1) | CA2332915C (enExample) |
| ID (1) | ID28277A (enExample) |
| NO (1) | NO20010119D0 (enExample) |
| NZ (1) | NZ508490A (enExample) |
| PL (1) | PL345340A1 (enExample) |
| WO (1) | WO2000002562A1 (enExample) |
| ZA (1) | ZA200007168B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0934061B3 (en) | 1996-07-24 | 2015-01-21 | Warner-Lambert Company LLC | Isobutylgaba and its derivatives for the treatment of pain |
| US6992109B1 (en) * | 1999-04-08 | 2006-01-31 | Segal Catherine A | Method for the treatment of incontinence |
| AU4334900A (en) * | 1999-04-09 | 2000-11-14 | Euro-Celtique S.A. | Sodium channel blocker compositions and the use thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| CN1274306C (zh) | 2001-09-03 | 2006-09-13 | 纽朗制药有限公司 | 包含加巴喷丁或其类似物和α－氨基酰胺的药物组合物及其止痛应用 |
| PT1727620E (pt) * | 2004-03-12 | 2007-11-05 | Warner Lambert Co | Ligandos de biofosfina c1-simétricos e a sua utilização na síntese assimétrica da pregabalina |
| DE602005009161D1 (de) * | 2004-04-01 | 2008-10-02 | Warner Lambert Co | Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese |
| CN1972904B (zh) * | 2004-06-21 | 2011-02-02 | 沃尼尔·朗伯有限责任公司 | 普瑞巴林和相关化合物的制备 |
| RS51411B (sr) * | 2004-09-10 | 2011-02-28 | Newron Pharmaceuticals S.P.A. | Upotreba (r)-(halobenziloksi) benzilamino-propanamida kao selektivnih modulatora natrijumovih i/ili kalcijumovih kanala |
| IN266803B (enExample) | 2005-12-22 | 2015-06-03 | Newron Pharm Spa | |
| US7645767B2 (en) * | 2006-08-31 | 2010-01-12 | Trinity Laboratories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
| CH699327B1 (de) | 2007-02-14 | 2010-03-15 | Oerlikon Heberlein Temco Wattw | Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden. |
| EP2184986A4 (en) | 2007-08-06 | 2010-12-15 | Trinity Lab Inc | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY |
| SG157299A1 (en) | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| US20100190752A1 (en) * | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
| WO2011141923A2 (en) | 2010-05-14 | 2011-11-17 | Lupin Limited | Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin |
| WO2012059797A1 (en) | 2010-11-04 | 2012-05-10 | Lupin Limited | Process for synthesis of (s) - pregabalin |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4656177A (en) * | 1982-07-22 | 1987-04-07 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
| US5248678A (en) * | 1992-06-30 | 1993-09-28 | Fractal Laboratories, Inc. | Methods for increasing arousal and alertness and for the amelioration of comatose states |
| EP0717624A1 (en) | 1993-09-07 | 1996-06-26 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
| US5443838A (en) | 1993-09-15 | 1995-08-22 | Koenig, Jr.; Steven M. | Nutritional supplementation system |
| DK0888286T3 (da) * | 1996-03-14 | 2002-02-18 | Warner Lambert Co | Nye substituerede cykliske aminosyrer som farmaceutiske midler |
| DE69733081T2 (de) | 1996-08-23 | 2006-05-11 | Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) | Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen |
| NZ334898A (en) | 1996-10-23 | 2000-09-29 | Warner Lambert Co | Substituted gamma aminobutyric acids as pharamceutical agents |
| WO1999012537A1 (en) * | 1997-09-08 | 1999-03-18 | Warner-Lambert Company | Analgesic compositions comprising anti-epileptic compounds and methods of using same |
-
1999
- 1999-06-18 PL PL99345340A patent/PL345340A1/xx not_active Application Discontinuation
- 1999-06-18 NZ NZ508490A patent/NZ508490A/en unknown
- 1999-06-18 BR BR9911917-0A patent/BR9911917A/pt not_active Application Discontinuation
- 1999-06-18 KR KR1020017000260A patent/KR20010071777A/ko not_active Ceased
- 1999-06-18 ID IDW20010054A patent/ID28277A/id unknown
- 1999-06-18 CA CA002332915A patent/CA2332915C/en not_active Expired - Fee Related
- 1999-06-18 JP JP2000558822A patent/JP2002520286A/ja not_active Withdrawn
- 1999-06-18 US US09/743,371 patent/US6326374B1/en not_active Expired - Fee Related
- 1999-06-18 AU AU46910/99A patent/AU772156B2/en not_active Ceased
- 1999-06-18 WO PCT/US1999/013670 patent/WO2000002562A1/en not_active Ceased
- 1999-06-18 EP EP99930357A patent/EP1094817A1/en not_active Ceased
-
2000
- 2000-12-04 ZA ZA200007168A patent/ZA200007168B/en unknown
-
2001
- 2001-01-08 NO NO20010119A patent/NO20010119D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000002562A1 (en) | 2000-01-20 |
| AU772156B2 (en) | 2004-04-08 |
| CA2332915A1 (en) | 2000-01-20 |
| ID28277A (id) | 2001-05-10 |
| NZ508490A (en) | 2003-08-29 |
| NO20010119L (no) | 2001-01-08 |
| ZA200007168B (en) | 2002-03-04 |
| JP2002520286A (ja) | 2002-07-09 |
| EP1094817A1 (en) | 2001-05-02 |
| US6326374B1 (en) | 2001-12-04 |
| KR20010071777A (ko) | 2001-07-31 |
| PL345340A1 (en) | 2001-12-17 |
| NO20010119D0 (no) | 2001-01-08 |
| AU4691099A (en) | 2000-02-01 |
| CA2332915C (en) | 2006-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0211390A (pt) | Tratamento de infecções da unha com no | |
| BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
| BR9713400A (pt) | Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese. | |
| UY24354A1 (es) | Composiciones farmacéuticas que contienen epinastina | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| BR9808348A (pt) | Alimento medicinal para diabéticos | |
| SE9502167L (sv) | Insulinanalog-kompositioner | |
| EP0975351A4 (en) | TREATMENT OF MULTIPLE Sclerosis BY TAKING OR INHALING COPOLYMER-1 | |
| BR0209127A (pt) | compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
| BR9900320A (pt) | Composição antimicrobiana | |
| BR9714517A (pt) | Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
| BR9804437A (pt) | Compostos para a osteoporose | |
| BR0209129A (pt) | Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos | |
| DE69905170T2 (de) | Thiazolopyrimidinderivate | |
| DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
| BR0212298A (pt) | Composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico | |
| ES2167717T3 (es) | Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos. | |
| AR003589A1 (es) | Utilizacion de una cantidad eficaz de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento destinada paratratar la inflamacion, y un procedimiento de tratamiento cosmetico mediante una composicion cosmetica que contiene a dicho peptido. | |
| BR9913072A (pt) | Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia | |
| EA199700032A1 (ru) | Дезинфицирующий состав "велтолен" | |
| BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
| BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
| ES2180948T3 (es) | Peptido que proviene de una forma soluble de la acetilcolinesterasa, activo como modulador del canal. | |
| CA2332915A1 (en) | Compositions comprising gaba analogs and caffeine | |
| BR9813996A (pt) | 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 31/52, A61K 31/197, A61P 29/00, A61P 25/04 Ipc: A61K 31/52 (2007.10), A61K 31/197 (2007.10), A61P |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |